NEW YORK (GenomeWeb) – Celldom said today that it has received a $1.5 million Phase II Small Business Innovation Research grant from the National Institutes of Health.
Celldom will use the award, administered by National Institute of General Medical Sciences, to advance the next generation of its high-throughput single cell analysis platform to analyze heterogeneity in cell populations for research and drug discovery.